Expert comment: ENZAMET and TITAN trials | Earle Burgess Medicine Matters oncology 2:58 5 years ago 271 Далее Скачать
Updated overall survival outcomes in ENZAMET (ANZUP 1304) European Association of Urology 6:40 2 years ago 530 Далее Скачать
Dr. Burgess on the Synergy Between Abiraterone and ADT in Prostate Cancer OncLive 1:11 6 years ago 250 Далее Скачать
Dr. Burgess on Key Data in Metastatic Castration-Sensitive Prostate Cancer OncLive 1:26 6 years ago 114 Далее Скачать
ASCO 2019 ENZAMET (ANZUP 1304) Trial results Plenary presentation ANZUP Cancer Trials Group 16:37 5 years ago 1 819 Далее Скачать
Dr. Burgess on Understanding Molecular Subtypes of Prostate Cancer OncLive 0:57 5 years ago 191 Далее Скачать
Dr. Sweeney on the Phase III ENZAMET Trial in Metastatic Hormone-Sensitive Prostate Cancer OncLive 2:46 5 years ago 816 Далее Скачать
Expert comment: Phase II trial of enfortumab vedotin in urothelial cancer | Robert Dreicer Medicine Matters oncology 1:26 5 years ago 82 Далее Скачать
Researcher comment: Apalutamide addition improves metastatic CSPC survival | Axel Merseburger Medicine Matters oncology 3:04 5 years ago 249 Далее Скачать
Dr. Chi on the TITAN Trial Results in Metastatic Castration-Sensitive Prostate Cancer OncLive 1:34 5 years ago 542 Далее Скачать
